$PRAN Recent News U.S. stocks rise; S&P 500, Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$PRAN Recent News

U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains 4:47 p.m. March 31, 2014 - Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses 3:30 p.m. March 31, 2014 - Sue Chang
Biotech's shares fall 70% on tests 12:39 p.m. March 31, 2014 - Russ Britt
U.S. stock futures extend gains ahead of Yellen 8:58 a.m. March 31, 2014 - Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial 7:50 a.m. March 31, 2014 - Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails 7:22 a.m. March 31, 2014 - Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 5:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results 4:24 p.m. Feb. 18, 2014 - Russ Britt
Prana's Huntington disease therapy meets endpoints 12:51 p.m. Feb. 18, 2014 - MarketWatch.com
Prana Biotechnology up 19% in premarket 9:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 2:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 3:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 11:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 1:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 11:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 10:20 a.m. March 22, 2011 - Val Brickates Kennedy


Why Prana Biotechnology (PRAN) Stock Is Surging Today 16 min ago - TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today 2:05 p.m. July 17, 2014 - TheStreet.com
Prana shares up premarket on clinical trial update 9:22 a.m. July 17, 2014 - Seeking Alpha
Prana Biotechnology (PRAN) Stock Suddenly Surges 3:28 p.m. May 27, 2014 - TheStreet.com
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure 4:15 p.m. April 14, 2014 - Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble? 11:16 a.m. April 14, 2014 - Seeking Alpha
Prana collapses after trial fails 6:57 a.m. March 31, 2014 - Seeking Alpha
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors 3:49 p.m. March 20, 2014 - Seeking Alpha
Prana to join Aussie index for top 300 companies 10:00 a.m. March 11, 2014 - Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations 9:38 a.m. March 7, 2014 - Seeking Alpha
Prana Biotech Alzheimer approach supported by study 11:49 a.m. March 6, 2014 - Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? 4:24 p.m. March 4, 2014 - Seeking Alpha
Prana: Right Drug, Wrong Dose 10:38 a.m. March 3, 2014 - Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results 7:45 a.m. March 1, 2014 - Seeking Alpha
Following The Latest In Alzheimer's Research As An Investor 11:12 a.m. Feb. 24, 2014 - Seeking Alpha
Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors 1:45 p.m. Feb. 22, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 20 8:30 a.m. Feb. 21, 2014 - Seeking Alpha
Prana Biotechnology And MannKind Corp.: Bad News Obeys Its Own Special Laws 1:33 p.m. Feb. 20, 2014 - Seeking Alpha
Company news for February 19, 2014 - Corporate Summary 11:06 a.m. Feb. 19, 2014 - Zacks.com
Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst 8:55 a.m. Feb. 19, 2014 - Seeking Alpha


Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease 7:45 a.m. Today - PR Newswire - PRF
Prana Alzheimer's disease Development Program update 4:10 p.m. July 17, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology 7:10 a.m. June 11, 2014 - PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics 11:29 a.m. May 19, 2014 - PR Newswire - PRF
World leader in movement disorders Professor Ira Shoulson joins Prana Board 7:30 a.m. May 14, 2014 - PR Newswire - PRF
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 11:34 a.m. April 23, 2014 - PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana Biotechnology Limited 9:03 a.m. April 23, 2014 - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 10:47 a.m. April 16, 2014 - ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 9:49 a.m. April 2, 2014 - ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year 2:00 a.m. April 1, 2014 - ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease 7:05 a.m. March 31, 2014 - PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 12:19 p.m. March 28, 2014 - PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective 9:30 a.m. March 4, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 1:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease 7:02 a.m. Feb. 18, 2014 - PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 9:00 a.m. Dec. 20, 2013 - PR Newswire
Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial 10:03 a.m. Dec. 10, 2013 - Marketwire
Prana Completes PBT2 Dosing in IMAGINE Alzheimer's Disease Clinical Trial 10:02 a.m. Dec. 9, 2013 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HawkEye 360 Expands with Advanced Satellite Launch

Updated Category News Views 4

Another Triumph for Signals Intelligence Launches come and go, but HawkEye 360's recent deployment of Cluster 16 isn't just another tick on their list. This satellite trio is kitted out with tech that propels the firm deeper into the realm of signals intelligence, where every second counts. The Art of Keeping Up with Demand Now, it's no simple feat to manage rocket...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 66

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Understanding New Jersey's Gun Laws Through Legal Eyes

Updated Category News Views 14

Cracking New Jersey's Complex Legal Code You ever try to decode the rulebook judges play by when gun possession and aggravated assault enter the picture in New Jersey? Well, it's as tricky as picking a safe with a wet noodle. Thankfully, a legal eagle named Ed Weinstock sheds some light on this murky terrain. Now, this isn't just some academic exercise—it's a look into...

Continue Reading
PlanetiQ’s GNSS-RO Expansion: New Satellites Launched

Updated Category News Views 5

PlanetiQ Sets New Pace with Satellite Launches Another day, another launch, eh? PlanetiQ is on a roll! The commercial provider of GNSS radio occultation (GNSS-RO) weather data isn't just resting on its laurels. This October alone, the outfit has blasted two new satellites into the great beyond. That's right, partner—they're stacking assets like poker chips. Quick...

Continue Reading
Americas Cardroom Smashes Prize Pools; Bahamas Up Next

Updated Category News Views 27

Ah, poker. Where dreams are won with a flick of the wrist and a well-placed bluff. This week, it was all eyes on Americas Cardroom’s Dual Venom PKOs, and let me tell you, they didn't just meet expectations—they chewed them up and spat them out like yesterday's jam. Two Titans Crowned in Poker Showdown The action wrapped up with a jaw-dropping $6,862,500 prize pool....

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 149

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 21

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Anavex Faces Securities Lawsuit: Investor Implications

Updated Category News Views 39

Storm Clouds Over Anavex: What Investors Need to Know If you've got a slice of Anavex Life Sciences Corp. (NASDAQ: AVXL) in your portfolio, the latest chapter of their legal saga feels less like a twist and more like a twist of the knife. These lawsuits often come out of left field for investors, but this one seems like a slow train that’s been gathering steam for a...

Continue Reading
FP Movement Opens Energizing Boutique in Cranston, RI

Updated Category News Views 23

FP Movement Expands with Style in Rhode Island FP Movement is shaking things up in Cranston, Rhode Island, bringing its signature activewear vibe to Garden City Center with a new shop. It’s not just about buying leggings anymore; it’s about diving into a lifestyle that screams energy and community spirit. The store, which spans 1,209 selling-square-feet, opened its...

Continue Reading
Malteurop's Big Bet in China: A Malt Monopoly Move

Updated Category News Views 4

Malteurop’s Ambitious Leap into China Folks, it looks like Malteurop, the malting arm of the French VIVESCIA Group, is digging its French roots deep into Chinese soil with a move that screams strategy. They’ve just scooped up the Chunlei Malting Co. plant in Jiangsu province, which cranks out enough malt to sling two billion liters of beer annually. Yeah, that's quite...

Continue Reading
blog__more"> More News Articles